Cargando…

COVID-19 in people living with diabetes: An international consensus

The COVID-19 pandemic has added an enormous toll to the existing challenge of diabetes care world-wide. A large proportion of patients with COVID-19 requiring hospitalization and/or succumbing to the disease have had diabetes and other chronic conditions as underlying risk factors. In particular, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Caballero, A.E., Ceriello, A., Misra, A., Aschner, P., McDonnell, M.E., Hassanein, M., Ji, L., Mbanya, J.C., Fonseca, V.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336933/
https://www.ncbi.nlm.nih.gov/pubmed/32651031
http://dx.doi.org/10.1016/j.jdiacomp.2020.107671
_version_ 1783554414370357248
author Caballero, A.E.
Ceriello, A.
Misra, A.
Aschner, P.
McDonnell, M.E.
Hassanein, M.
Ji, L.
Mbanya, J.C.
Fonseca, V.A.
author_facet Caballero, A.E.
Ceriello, A.
Misra, A.
Aschner, P.
McDonnell, M.E.
Hassanein, M.
Ji, L.
Mbanya, J.C.
Fonseca, V.A.
author_sort Caballero, A.E.
collection PubMed
description The COVID-19 pandemic has added an enormous toll to the existing challenge of diabetes care world-wide. A large proportion of patients with COVID-19 requiring hospitalization and/or succumbing to the disease have had diabetes and other chronic conditions as underlying risk factors. In particular, individuals belonging to racial/ethnic minorities in the U.S. and other countries have been significantly and disproportionately impacted. Multiple and complex socioeconomic factors have long played a role in increasing the risk for diabetes and now for COVID-19. Since the pandemic began, the global healthcare community has accumulated invaluable clinical experience on providing diabetes care in the setting of COVID-19. In addition, understanding of the pathophysiological mechanisms that link these two diseases is being developed. The current clinical management of diabetes is a work in progress, requiring a shift in patient-provider interaction beyond the walls of clinics and hospitals: the use of tele-medicine when feasible, innovative patient education programs, strategies to ensure medication and glucose testing availability and affordability, as well as numerous ideas on how to improve meal plans and physical activity. Notably, this worldwide experience offers us the possibility to not only prepare better for future disasters but also transform diabetes care beyond the COVID-19 era.
format Online
Article
Text
id pubmed-7336933
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-73369332020-07-06 COVID-19 in people living with diabetes: An international consensus Caballero, A.E. Ceriello, A. Misra, A. Aschner, P. McDonnell, M.E. Hassanein, M. Ji, L. Mbanya, J.C. Fonseca, V.A. J Diabetes Complications Article The COVID-19 pandemic has added an enormous toll to the existing challenge of diabetes care world-wide. A large proportion of patients with COVID-19 requiring hospitalization and/or succumbing to the disease have had diabetes and other chronic conditions as underlying risk factors. In particular, individuals belonging to racial/ethnic minorities in the U.S. and other countries have been significantly and disproportionately impacted. Multiple and complex socioeconomic factors have long played a role in increasing the risk for diabetes and now for COVID-19. Since the pandemic began, the global healthcare community has accumulated invaluable clinical experience on providing diabetes care in the setting of COVID-19. In addition, understanding of the pathophysiological mechanisms that link these two diseases is being developed. The current clinical management of diabetes is a work in progress, requiring a shift in patient-provider interaction beyond the walls of clinics and hospitals: the use of tele-medicine when feasible, innovative patient education programs, strategies to ensure medication and glucose testing availability and affordability, as well as numerous ideas on how to improve meal plans and physical activity. Notably, this worldwide experience offers us the possibility to not only prepare better for future disasters but also transform diabetes care beyond the COVID-19 era. Elsevier Inc. 2020-09 2020-07-06 /pmc/articles/PMC7336933/ /pubmed/32651031 http://dx.doi.org/10.1016/j.jdiacomp.2020.107671 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Caballero, A.E.
Ceriello, A.
Misra, A.
Aschner, P.
McDonnell, M.E.
Hassanein, M.
Ji, L.
Mbanya, J.C.
Fonseca, V.A.
COVID-19 in people living with diabetes: An international consensus
title COVID-19 in people living with diabetes: An international consensus
title_full COVID-19 in people living with diabetes: An international consensus
title_fullStr COVID-19 in people living with diabetes: An international consensus
title_full_unstemmed COVID-19 in people living with diabetes: An international consensus
title_short COVID-19 in people living with diabetes: An international consensus
title_sort covid-19 in people living with diabetes: an international consensus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336933/
https://www.ncbi.nlm.nih.gov/pubmed/32651031
http://dx.doi.org/10.1016/j.jdiacomp.2020.107671
work_keys_str_mv AT caballeroae covid19inpeoplelivingwithdiabetesaninternationalconsensus
AT cerielloa covid19inpeoplelivingwithdiabetesaninternationalconsensus
AT misraa covid19inpeoplelivingwithdiabetesaninternationalconsensus
AT aschnerp covid19inpeoplelivingwithdiabetesaninternationalconsensus
AT mcdonnellme covid19inpeoplelivingwithdiabetesaninternationalconsensus
AT hassaneinm covid19inpeoplelivingwithdiabetesaninternationalconsensus
AT jil covid19inpeoplelivingwithdiabetesaninternationalconsensus
AT mbanyajc covid19inpeoplelivingwithdiabetesaninternationalconsensus
AT fonsecava covid19inpeoplelivingwithdiabetesaninternationalconsensus